Study Bolsters Evidence that Effects of Puberty Blockers Are Reversible

Medications commonly known as puberty blockers were found to delay development of female reproductive organs but allow for restoration of reproductive functioning after the medications were withdrawn, according to a new study being presented this week at the American Physiology Summit.

Expert group proposes revisions to guidelines for gender-affirming health care

Transgender and gender-diverse (TGD) people often seek social, medical, and surgical gender-affirming care from a variety of healthcare professionals. Individualized care for optimal gender identity confirmation should be the main goal, rather than strict rules to guide interventions, according to an expert panel’s commentary in the November issue of Harvard Review of Psychiatry (HRP). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Gender Affirmation Treatment Delivery Route May Affect Heart Health

Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.

Rural, transgender populations face greater healthcare disparities, WVU research show

New research from West Virginia University suggests that transgender and gender diverse individuals in rural areas face greater challenges receiving basic healthcare needs than their counterparts. Up to 61% of participants said they had to travel out of state for gender-related care, while over one-third reported they avoid seeking healthcare altogether for fear of discrimination.